Alexandra Gylfe

Alexandra Gylfe, PhD, is a founding partner at Nordic Science Investments and a board member at multiple organizations, including Thestra and Solid IO, focused on advancing cancer diagnostics and treatment. They have held significant roles in business development, including director positions at Helsinki Innovation Services and iCAN, where they facilitated partnerships in precision medicine. Gylfe was a senior manager at Human Longevity, Inc., leading efforts in cancer genomics, and has contributed to academia as a visiting researcher at Stanford University School of Medicine. Their educational background spans institutions such as Stanford and the University of Helsinki.